8-K
Current Report
Viridian Therapeutics, Inc.DE Filed Acc 0001193125-25-168614
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d24708d8k.htm…